In addition, TPH-1 overexpressing LN229/T98G cells exhibited enhanced resistance to the chemotherapeutic agent, TMZ (Fig. 1F), suggesting that a high level of TPH-1 resulted in enhanced tumor growth and reduced chemo-sensitivity in glioma. This evidence concerns the gene TPH1 and glioma.